133
Views
1
CrossRef citations to date
0
Altmetric
FLUORESCENCE

Determination of DNA Methyltransferase 1 in Cells Using a RG108-Fluorescein Conjugate to Monitor the Fluorescent Ratio with a Microplate Reader

, , , , , & show all
Pages 1660-1674 | Received 10 Jul 2022, Accepted 20 Oct 2022, Published online: 29 Oct 2022

References

  • Adam, S., H. Anteneh, M. Hornisch, V. Wagner, J. Lu, N. E. Radde, P. Bashtrykov, J. Song, and A. Jeltsch. 2020. DNA sequence-dependent activity and base flipping mechanisms of DNMT1 regulate genome-wide DNA methylation. Nature Communications 11 (1):3723.
  • Akone, S. H., F. Ntie-Kang, F. Stuhldreier, M. B. Ewonkem, A. M. Noah, S. E. M. Mouelle, and R. Muller. 2020. Natural products impacting DNA methyltransferases and histone deacetylases. Frontiers in Pharmacology 11:992. doi:10.3389/fphar.2020.00992.
  • Asgatay, S., C. Champion, G. Marloie, T. Drujon, C. Senamaud-Beaufort, A. Ceccaldi, A. Erdmann, A. Rajavelu, P. Schambel, A. Jeltsch, et al. 2014. Synthesis and evaluation of analogues of N-phthaloyl-L-tryptophan (RG108) as inhibitors of DNA methyltransferase 1. Journal of Medicinal Chemistry 57 (2):421–34.
  • Brueckner, B., R. G. Boy, P. Siedlecki, T. Musch, H. C. Kliem, P. Zielenkiewicz, S. Suhai, M. Wiessler, and F. Lyko. 2005. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Research 65 (14):6305–11. doi:10.1158/0008-5472.CAN-04-2957.
  • Brena, R. M., H. Auer, K. Kornacker, B. Hackanson, A. Raval, J. C. Byrd, and C. Plass. 2006. Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 bioanalyzer platform. Nucleic Acids Research 34 (3):e17. doi:10.1093/nar/gnj017.
  • Dekevic, G., L. Tasto, P. Czermak, and D. Salzig. 2022. Statistical experimental designs to optimize the transient transfection of HEK 293T cells and determine a transfer criterion from adherent cells to larger-scale cell suspension cultures. Journal of Biotechnology 346:23–34. doi:10.1016/j.jbiotec.2022.01.004.
  • Greenberg, M. V. C, and D. Bourc’his. 2019. The diverse roles of DNA methylation in mammalian development and disease. Nature Reviews. Molecular Cell Biology 20 (10):590–607.
  • Honeywell, R. J., D. Sarkisjan, M. H. Kristensen, D. J. Klerk, and G. J. Peters. 2018. DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors. Nucleosides, Nucleotides & Nucleic Acids 37 (12):696–708. doi:10.1080/15257770.2018.1498516.
  • Jeltsch, A., S. Adam, M. Dukatz, M. Emperle, and P. Bashtrykov. 2021. Deep enzymology studies on DNA methyltransferases reveal novel connections between flanking sequences and enzyme activity. Journal of Molecular Biology 433 (19):167186.
  • Kim, B. Y., O. S. Kwon, S. A. Joo, J. A. Park, K. Y. Heo, M. S. Kim, and J. S. Ahn. 2004. A column method for determination of DNA cytosine-C5-methyltransferase activity. Analytical Biochemistry 326 (1):21–4.
  • Kulis, M, and M. Esteller. 2010. DNA methylation and cancer. Advances in Genetics 70:27–56. doi:10.1016/B978-0-12-380866-0.60002-2.
  • Li, Y., X. Zou, F. Ma, B. Tang, and C.-Y. Zhang. 2017. Development of fluorescent methods for DNA methyltransferase assay. Methods and Applications in Fluorescence 5 (1):012002. doi:10.1088/2050-6120/aa6127.
  • Lin, Y.-C., M. Boone, L. Meuris, I. Lemmens, N. Van Roy, A. Soete, J. Reumers, M. Moisse, S. Plaisance, R. Drmanac, et al. 2014. Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations. Nature Communications 5:4767.
  • Long, Y., K. Ubych, E. Jagu, and R. K. Neely. 2021. FRET-based method for direct, real-time measurement of DNA methyltransferase activity. Bioconjugate Chemistry 32 (1):192–8.
  • Micevic, G., N. Theodosakis, and M. Bosenberg. 2017. Aberrant DNA methylation in melanoma: Biomarker and therapeutic opportunities. Clinical Epigenetics 9 (34):34.
  • Molnár, B., O. Galamb, B. Péterfia, B. Wichmann, I. Csabai, A. Bodor, A. Kalmár, K. A. Szigeti, B. K. Barták, Z. B. Nagy, et al. 2018. Gene promoter and exon DNA methylation changes in colon cancer development – mRNA expression and tumor mutation alterations. BMC Cancer 18 (1):695. doi:10.1186/s12885-018-4609-x.
  • Mulero-Navarro, S, and M. Esteller. 2008. Epigenetic biomarkers for human cancer: The time is now. Critical Reviews in Oncology/Hematology 68 (1):1–11. doi:10.1016/j.critrevonc.2008.03.001.
  • Ongenaert, M., G. B A. Wisman, H. H. Volders, A. J. Koning, A. G. Zee, W. Criekinge, and E. Schuuring. 2008. Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Medical Genomics 1 (57):57.
  • Pappalardi, M. B., K. Keenan, M. Cockerill, W. A. Kellner, A. Stowell, C. Sherk, K. Wong, S. Pathuri, J. Briand, M. Steidel, et al. 2021. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nature Cancer 2 (10):1002–17.
  • Poh, W. J., C. P. P. Wee, and Z. Gao. 2016. DNA methyltransferase activity assays: Advances and challenges. Theranostics 6 (3):369–91. doi:10.7150/thno.13438.
  • Portilho, N. A., D. Saini, I. Hossain, J. Sirois, C. Moraes, and W. A. Pastor. 2021. The DNMT1 inhibitor GSK-3484862 mediates global demethylation in murine embryonic stem cells. Epigenetics & Chromatin 14 (1):56.
  • Ren, W., L. Gao, and J. Song. 2018. Structural basis of DNMT1 and DNMT3A-mediated DNA methylation. Genes 9 (12):620. doi:10.3390/genes9120620.
  • Rohde, C., Y. Zhang, R. Reinhardt, and A. Jeltsch. 2010. BISMA–fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences. BMC Bioinformatics 11:230. doi:10.1186/1471-2105-11-230.
  • Ruan, M., Q. Cheng, C. Gong, Z. Cao, L. Xu, and Q. Zhang. 2020. Development of a kind of RG108-Fluorescein conjugates for detection of DNA methyltransferase 1 (DNMT1) in living cells. Analytical Biochemistry 607:113823. doi:10.1016/j.ab.2020.113823.
  • She, S., Y. Zhao, B. Kang, C. Chen, X. Chen, X. Zhang, W. Chen, S. Dan, H. Wang, Y.-J. Wang, et al. 2020. Combined inhibition of JAK1/2 and DNMT1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells. Cell Death & Disease 11 (9):724. doi:10.1038/s41419-020-02934-8.
  • Suzuki, T., R. Tanaka, S. Hamada, H. Nakagawa, and N. Miyata. 2010. Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters 20 (3):1124–7.
  • Wang, Z. Y., P. Li, L. Cui, Q. Xu, and C. Zhang. 2020. Construction of a universal and label-free chemiluminescent sensor for accurate quantification of both bacteria and human methyltransferases. Analytical Chemistry 92 (19):13573–80.
  • Xu, J., L. Xu, B. Yang, L. Wang, X. Lin, and H. Tu. 2015. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer. International Journal of Clinical and Experimental Pathology 8 (2):1674–81.
  • Zhang, Y., F. Chen, Y. Sun, S. Zhou, T. Li, and R. Chen. 2011. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells. Journal of Experimental & Clinical Cancer Research: CR 30 (98):98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.